Franklin Resources
PHAT icon

Franklin Resources’s Phathom Pharmaceuticals PHAT Stock Holding History

Franklin Resources’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.4M Buy
1,970,828
+976,324
+98% +$11.1M ﹤0.01% 992
2026
Q1 		$11M Buy
+994,504
New +$12.6M ﹤0.01% 1196

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Franklin Resources's PHAT Position: Q2 2026 in Review

Franklin Resources increased its Phathom Pharmaceuticals (PHAT) stake by 98% in Q2 2026, buying an estimated $11.1M and bringing the position to 1,970,828 shares worth $21.4M. The position accounts for ﹤0.01% of the portfolio, ranked #992.

Franklin Resources first reported a position in PHAT in Q1 2026 and has held it in 2 quarters since. 162 funds tracked by Wall St. Rank hold PHAT as of Q2 2026.

  • Franklin Resources held 1,970,828 shares of Phathom Pharmaceuticals worth $21.4M as of Q2 2026.
  • Franklin Resources bought 976,324 Phathom Pharmaceuticals shares in Q2 2026, an estimated $11.1M.
  • Phathom Pharmaceuticals made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #992 holding.
  • Franklin Resources first reported a position in Phathom Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 162 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.